TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+10.56%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.98B
AUM Growth
+$171M
(+9.4%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
220
New
18
Increased
34
Reduced
52
Closed
20
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$28.3M |
| 2 |
Merus
MRUS
|
$26.3M |
| 3 |
Mettler-Toledo International
MTD
|
$22.9M |
| 4 |
Boeing
BA
|
$20.9M |
| 5 |
Spyre Therapeutics
SYRE
|
$17.2M |
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$37.7M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$29M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
| 4 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 5 |
CRISPR Therapeutics
CRSP
|
$9.07M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Technology | 1.37% |
| 3 | Industrials | 1.32% |
| 4 | Communication Services | 1.26% |
| 5 | Consumer Discretionary | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Neumora Therapeutics
NMRA
$264M
| $1.03M | 0.05% |
1,400,000
| – | – |
|
152
Aligos Therapeutics
ALGS
$74.7M
| $1.02M | 0.05% |
141,131
| – | – |
|
153
American Express
AXP
$230B
| $1.01M | 0.05% |
3,168
-498
| -14% | -$159K |
|
|
AAT
154
American Assets Trust
AAT
$1.26B
| $988K | 0.05% |
50,000
| – | – |
|
|
KLRS
155
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
| $963K | 0.05% |
360,859
+51,638
| +17% | +$138K |
|
156
Bolt Biotherapeutics
BOLT
$9.29M
| $963K | 0.05% |
166,879
-23,760
| -12% | -$137K |
|
157
Enanta Pharmaceuticals
ENTA
$190M
| $958K | 0.05% |
126,655
| – | – |
|
158
Amazon
AMZN
$2.51T
| $947K | 0.05% |
4,314
-581
| -12% | -$127K |
|
159
Tempest Therapeutics
TPST
$44.5M
| $945K | 0.05% |
+138,962
| New | +$945K |
|
160
T-Mobile US
TMUS
$284B
| $904K | 0.05% |
3,796
-532
| -12% | -$127K |
|
161
Allstate
ALL
$54.9B
| $903K | 0.05% |
4,488
-624
| -12% | -$126K |
|
162
Corbus Pharmaceuticals
CRBP
$123M
| $880K | 0.04% |
127,520
| – | – |
|
163
Paychex
PAYX
$49.4B
| $880K | 0.04% |
6,048
-640
| -10% | -$93.1K |
|
164
TScan Therapeutics
TCRX
$107M
| $870K | 0.04% |
600,000
| – | – |
|
165
McDonald's
MCD
$226B
| $854K | 0.04% |
2,925
-303
| -9% | -$88.5K |
|
166
Hormel Foods
HRL
$13.9B
| $850K | 0.04% |
28,094
-2,370
| -8% | -$71.7K |
|
167
UnitedHealth
UNH
$281B
| $849K | 0.04% |
2,721
-820
| -23% | -$256K |
|
168
Hewlett Packard
HPE
$30.4B
| $818K | 0.04% |
40,002
-4,545
| -10% | -$92.9K |
|
169
Ford
F
$46.5B
| $818K | 0.04% |
75,380
-6,347
| -8% | -$68.9K |
|
|
CBIO
170
Crescent Biopharma, Inc. Common Stock
CBIO
$190M
| $809K | 0.04% |
+50,152
| New | +$809K |
|
171
Sherwin-Williams
SHW
$91.2B
| $805K | 0.04% |
2,343
-305
| -12% | -$105K |
|
172
United Airlines
UAL
$34.3B
| $801K | 0.04% |
10,065
-1,928
| -16% | -$154K |
|
173
Whirlpool
WHR
$5.14B
| $766K | 0.04% |
7,553
-610
| -7% | -$61.9K |
|
174
Sealed Air
SEE
$4.75B
| $757K | 0.04% |
24,400
-2,546
| -9% | -$79K |
|
175
Applied Therapeutics
APLT
$67M
| $755K | 0.04% |
2,428,169
| – | – |
|